Mario Negri Institute For Pharmacological Research
Clinical trials sponsored by Mario Negri Institute For Pharmacological Research, explained in plain language.
-
New combo therapy aims to stall rare Cancer's return
Disease control CompletedThis study tested whether adding pioglitazone (a diabetes drug) to trabectedin (a chemotherapy) can better control liposarcoma, a rare soft-tissue cancer. Ten adults whose tumors had stopped growing on trabectedin alone received the combination. The goal was to see if the combo c…
Phase: PHASE2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
School-Family programs aim to stop childhood obesity before it starts
Prevention CompletedThis completed study tested whether programs involving schools and families could help prevent childhood obesity in 226 children aged 6 to 11. Researchers measured children's weight, diet quality, and family habits to see if these programs encouraged healthier lifestyles. The goa…
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Prevention
Last updated May 17, 2026 03:42 UTC
-
Scientists probe immune cells to unlock kidney disease remission secrets
Knowledge-focused CompletedThis study looked at blood samples from 48 people with membranous nephropathy, a kidney disease, to see how treatments that deplete B-cells affect specific immune cells linked to the disease. Researchers tracked these cells over time in patients who got better, relapsed, or didn'…
Phase: NA • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Bergamo gene clue: new mutation found in kidney disease patients
Knowledge-focused CompletedThis study examined 10 people with autosomal dominant polycystic kidney disease (ADPKD) to see if a specific missing piece in the PKD2 gene is shared among families in the Bergamo area. Researchers collected medical histories and DNA samples to understand how this gene change aff…
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC